Physician profile
Vesta D Mcdowell
NPI 1639145147
$39,306.55
in general payments reported to CMS, 2019-2025
14 companies · $47.23 in 2025
The $47.23 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $88.95 · 2021: $354 · 2022: $1,858 · 2023: $24.10 · 2024: $37K · 2025: $47.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $36K · Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $36,400.00 |
| Food and Beverage | $202.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36,400.00 | 2024 | |
| Triad Life Sciences INC. | $1,649.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $343.87 | 2021-2023 | Nuzyra |
| Smith+Nephew, INC. | $337.07 | 2019-2025 | Grafix Pl, Stravix Pl |
| Organogenesis INC. | $205.19 | 2019-2022 | |
| Abbott Laboratories | $148.89 | 2019 | |
| Sebela Pharmaceuticals INC. | $49.78 | 2020-2022 | |
| Tactile Systems Technology INC | $45.45 | 2019 | |
| Melinta Therapeutics, LLC | $41.11 | 2019 | |
| Stryker Corporation | $32.23 | 2022 | |
| Merck Sharp & Dohme LLC | $15.99 | 2019 | |
| Integra Lifesciences Corporation | $13.77 | 2020 | |
| Kci USA, INC. | $12.63 | 2020 | |
| Horizon Therapeutics Plc | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vesta Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.